Han, Xianlin Rozen, Steve H. Boyle, Stephen Hellegers, Caroline Cheng, Hua Burke, James R. A. Welsh-Bohmer, Kathleen Murali Doraiswamy, P. Kaddurah-Daouk, Rima Lower sphingomyelins and higher ceramides in Alzheimer's patients are independent of statin use. <p>Panel A shows the differences in sphingomyelin and ceramide mass levels between AD patients and controls who were taking statins. For this comparison, P = 7×10<sup>−4</sup> for sphingomyelins and P = 0.00054 for ceramides (Wilcoxon signed rank test). Panel B shows the differences of sphingomyelin and ceramide mass levels between AD patients and controls who were not taking statins. For this comparison, P = 3.2×10<sup>−8</sup> for sphingomyelins and P = 0.0056 for ceramides (Wilcoxon signed rank test).</p> sphingomyelins;higher;ceramides;patients;statin 2013-02-20
    https://plos.figshare.com/articles/figure/_Lower_sphingomyelins_and_higher_ceramides_in_Alzheimer_s_patients_are_independent_of_statin_use_/428177
10.1371/journal.pone.0021643.g008